Midatech Pharma Plc (MTP) SEC Filing 6-K Foreign Issuer report for the period ending Friday, October 4, 2019

Midatech Pharma Plc

CIK: 1643918 Ticker: MTP

View differences made from one to another to evaluate Midatech Pharma Plc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Midatech Pharma Plc.


Assess how Midatech Pharma Plc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Midatech Pharma Plc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Material Contracts, Statements, Certifications & more

Midatech Pharma Plc provided additional information to their SEC Filing as exhibits

Ticker: MTP
CIK: 1643918
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001214659-19-006242
Submitted to the SEC: Mon Oct 07 2019 6:09:06 AM EST
Accepted by the SEC: Mon Oct 07 2019
Period: Friday, October 4, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: